• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利基于人群的 EQ-5D 健康状态值。

Italian population-based values of EQ-5D health states.

机构信息

CHARTA Foundation, Milan, Italy.

出版信息

Value Health. 2013 Jul-Aug;16(5):814-22. doi: 10.1016/j.jval.2013.04.008. Epub 2013 Jun 19.

DOI:10.1016/j.jval.2013.04.008
PMID:23947975
Abstract

OBJECTIVE

To estimate a value set for the calculation of Italian-specific quality-adjusted life years (QALYs), based on preferences elicited on EuroQol five-dimensional (EQ-5D) questionnaire health states using the time trade-off technique.

METHODS

The revised standard Measurement and Valuation of Health protocol was followed. Twenty-five health states, divided into three groups and given to 450 subjects, were selected to obtain 300 observations per state. Subjects aged 18 to 75 years were recruited to be representative of the Italian general adult population for age, sex, and geographical distribution. To improve efficiency, face-to-face interviews were conducted by using the Computer Assisted Personal Interviewing approach. Several random effects regression models were tested to predict the full set of EQ-5D questionnaire health states. Model selection was based on logical consistency of the estimates, sign and magnitude of the regression coefficients, goodness of fit, and parsimony.

RESULTS

The model that satisfied the criteria of logical consistency and was more efficient includes 10 main effect dummy variables for the EQ-5D questionnaire domain levels and the D1 interaction term, which accounts for the number of dimensions at levels 2 or 3 beyond the first. This model has an R(2) of 0.389 and a mean absolute error of 0.03, which are comparable to or better than those of models used in other countries. The utility estimates after state 11111 range from 0.92 (21111) to -0.38 (33333). Italian utility estimates are higher than those estimated in the United Kingdom and Spain and used so far to assess QALYs and conduct cost-utility evaluations in Italy.

CONCLUSIONS

A specific value set is now available to calculate QALYs for the conduction of health economic studies targeted at the Italian health care system.

摘要

目的

基于时间权衡技术对欧洲五维健康量表(EQ-5D)问卷健康状况的偏好评估,估算用于计算意大利特异性质量调整生命年(QALYs)的效用量值。

方法

遵循修订后的健康测量与评估标准协议。选择了 25 种健康状态,分为三组,分配给 450 名受试者,每个状态获得 300 个观察值。招募年龄在 18 至 75 岁的受试者,以代表意大利普通成年人群的年龄、性别和地域分布。为了提高效率,采用计算机辅助个人访谈方法进行面对面访谈。测试了几种随机效应回归模型来预测 EQ-5D 问卷健康状态的全部数据集。模型选择基于估计的逻辑一致性、回归系数的符号和大小、拟合优度和简约性。

结果

满足逻辑一致性标准且效率更高的模型包括 EQ-5D 问卷域水平的 10 个主效应虚拟变量和 D1 交互项,该交互项考虑了超出第一级的第二级或第三级的维度数量。该模型的 R(2)为 0.389,平均绝对误差为 0.03,与其他国家使用的模型相当或更好。状态 11111 之后的效用估计值范围从 0.92(21111)到-0.38(33333)。意大利的效用估计值高于在英国和西班牙进行的效用评估中估计的数值,并且迄今为止,这些数值一直用于评估意大利的 QALYs 和进行成本效用评估。

结论

现在有了一个特定的效用量值集,可以用于对意大利医疗保健系统进行的健康经济研究计算 QALYs。

相似文献

1
Italian population-based values of EQ-5D health states.意大利基于人群的 EQ-5D 健康状态值。
Value Health. 2013 Jul-Aug;16(5):814-22. doi: 10.1016/j.jval.2013.04.008. Epub 2013 Jun 19.
2
Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.比较三种欧洲国家用 EQ-5D 衡量的人口健康状况的不同评估方法。
Value Health. 2009 Jul-Aug;12(5):750-8. doi: 10.1111/j.1524-4733.2009.00509.x.
3
Social valuation of EQ-5D health states: the Chilean case.社会对 EQ-5D 健康状况的评估:智利案例。
Value Health. 2011 Dec;14(8):1135-41. doi: 10.1016/j.jval.2011.09.002. Epub 2011 Nov 6.
4
Chinese time trade-off values for EQ-5D health states.中国人群 EQ-5D 量表健康状态时间权衡值。
Value Health. 2014 Jul;17(5):597-604. doi: 10.1016/j.jval.2014.05.007. Epub 2014 Jul 23.
5
Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values.峰区之尾:调整后的 EQ-5D 问卷健康状态效用值有限依赖变量混合模型。
Value Health. 2012 May;15(3):550-61. doi: 10.1016/j.jval.2011.12.014. Epub 2012 Mar 23.
6
Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.评估类风湿关节炎中的效用值:时间权衡法与欧洲五维度健康量表的比较
Arthritis Rheum. 2006 Oct 15;55(5):751-6. doi: 10.1002/art.22226.
7
Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.质量调整生命年在儿科护理中缺乏质量:对已发表的儿童健康成本效用研究的批判性综述。
Pediatrics. 2005 May;115(5):e600-14. doi: 10.1542/peds.2004-2127.
8
A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.一种用于获取健康状态偏好的混合建模方法:葡萄牙 EQ-5D-5L 值集。
Qual Life Res. 2019 Dec;28(12):3163-3175. doi: 10.1007/s11136-019-02226-5. Epub 2019 Jun 14.
9
Time trade-off derived EQ-5D weights for Australia.澳大利亚时间权衡法衍生的 EQ-5D 权重。
Value Health. 2011 Sep-Oct;14(6):928-36. doi: 10.1016/j.jval.2011.04.009. Epub 2011 Aug 4.
10
Estimating quality weights for EQ-5D (EuroQol-5 dimensions) health states with the time trade-off method in Taiwan.采用时间权衡法评估台湾 EQ-5D(欧洲五维健康量表)健康状态的质量权重。
J Formos Med Assoc. 2013 Nov;112(11):699-706. doi: 10.1016/j.jfma.2012.12.015. Epub 2013 Feb 12.

引用本文的文献

1
Validation of the cancer-specific utility measure EORTC QLU-C10D using evidence from four lung cancer trials covering six country value sets.利用来自四项涵盖六个国家价值集的肺癌试验的证据,对癌症特异性效用测量指标EORTC QLU-C10D进行验证。
Sci Rep. 2025 Apr 28;15(1):14907. doi: 10.1038/s41598-024-83861-y.
2
A Cost-Effectiveness Analysis of Mosunetuzumab vs Tisagenlecleucel for Treatment of Third- or Higher-Line (3L+) Relapsed or Refractory (R/R) Follicular Lymphoma (FL) in Italy.在意大利,莫苏奈妥珠单抗与替沙格赛定用于治疗三线或更高线(3L+)复发或难治性(R/R)滤泡性淋巴瘤(FL)的成本效益分析。
Clinicoecon Outcomes Res. 2025 Apr 16;17:335-348. doi: 10.2147/CEOR.S509907. eCollection 2025.
3
A Head-On Comparison of EQ-VT- and Crosswalk-Based EQ-5D-5L Value Sets.
基于EQ-VT和人行横道法的EQ-5D-5L值集的直接比较。
Appl Health Econ Health Policy. 2025 Mar 11. doi: 10.1007/s40258-025-00954-z.
4
Economic burden of multiple sclerosis in an Italian cohort of patients on disease-modifying therapy: analysis of disease cost and its components.意大利接受疾病修正治疗的多发性硬化症患者队列的经济负担:疾病成本及其构成分析。
J Neurol. 2024 Dec 12;272(1):50. doi: 10.1007/s00415-024-12729-y.
5
Valuation of the EQ-5D-3L in Jordan.约旦EQ-5D-3L量表的估值
Eur J Health Econ. 2025 Apr;26(3):487-501. doi: 10.1007/s10198-024-01712-z. Epub 2024 Sep 3.
6
Cancer-Specific Health Utilities: Evaluation of Core Measurement Properties of the EORTC QLU-C10D in Lung Cancer Patients-Data from Four Multicentre LUX-Lung Trials, Applying Six Country Tariffs.癌症特异性健康效用值:对肺癌患者中欧洲癌症研究与治疗组织QLU-C10D核心测量属性的评估——来自四项多中心LUX-Lung试验的数据,采用六个国家的关税标准
Pharmacoecon Open. 2024 Jul;8(4):627-640. doi: 10.1007/s41669-024-00484-9. Epub 2024 May 2.
7
Quality of Life and Sexual Function after Laparoscopic Posterior Vaginal Plication Plus Sacral Colpopexy for Severe Posterior Vaginal Prolapse.腹腔镜下阴道后壁折叠术联合骶骨阴道固定术治疗严重阴道后壁脱垂后的生活质量和性功能
J Clin Med. 2024 Jan 22;13(2):616. doi: 10.3390/jcm13020616.
8
Cost-effectiveness for high dose quadrivalent versus the adjuvanted quadrivalent influenza vaccine in the Italian older adult population.高剂量四价流感疫苗与佐剂四价流感疫苗在意大利老年人群中的成本效益比较。
Front Public Health. 2023 Nov 13;11:1200116. doi: 10.3389/fpubh.2023.1200116. eCollection 2023.
9
Work Difficulties in People with Multiple Sclerosis.多发性硬化症患者的工作困难。
J Occup Rehabil. 2024 Sep;34(3):606-617. doi: 10.1007/s10926-023-10149-9. Epub 2023 Nov 3.
10
Cost-effectiveness analysis of abemaciclib with endocrine therapy (ET) versus ET alone for HR+, HER2-, node-positive, high-risk early breast cancer in Italy.在意大利,阿贝西利联合内分泌治疗(ET)与单纯内分泌治疗相比,用于HR +、HER2 -、淋巴结阳性、高危早期乳腺癌的成本效益分析。
Glob Reg Health Technol Assess. 2023 Sep 28;10:62-69. doi: 10.33393/grhta.2023.2561. eCollection 2023 Jan-Dec.